3.19.2 html 81 225 1 false 37 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20190331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Audited Consolidated Balance Sheet as of December 31, 2018 and Unaudited Interim Condensed Consolidated Balance Sheet as of March 31, 2019 Sheet http://www.beyondspringpharma.com/20190331/role/statement-audited-consolidated-balance-sheet-as-of-december-31-2018-and-unaudited-interim-condensed-consolidated-balance-sheet-as-of-march-31-2019 Audited Consolidated Balance Sheet as of December 31, 2018 and Unaudited Interim Condensed Consolidated Balance Sheet as of March 31, 2019 Statements 2 false false R3.htm 002 - Statement - Audited Consolidated Balance Sheet as of December 31, 2018 and Unaudited Interim Condensed Consolidated Balance Sheet as of March 31, 2019 (Parentheticals) Sheet http://www.beyondspringpharma.com/20190331/role/statement-audited-consolidated-balance-sheet-as-of-december-31-2018-and-unaudited-interim-condensed-consolidated-balance-sheet-as-of-march-31-2019-parentheticals Audited Consolidated Balance Sheet as of December 31, 2018 and Unaudited Interim Condensed Consolidated Balance Sheet as of March 31, 2019 (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2018 and 2019 Sheet http://www.beyondspringpharma.com/20190331/role/statement-unaudited-interim-condensed-consolidated-statements-of-comprehensive-loss-for-the-three-months-ended-march-31-2018-and-2019- Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2018 and 2019 Statements 4 false false R5.htm 004 - Statement - Unaudited Interim Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2018 and 2019 Sheet http://www.beyondspringpharma.com/20190331/role/statement-unaudited-interim-condensed-consolidated-statements-of-cash-flows-for-the-three-months-ended-march-31-2018-and-2019- Unaudited Interim Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2018 and 2019 Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Nature of the Business and Basis of Preparation Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-1-nature-of-the-business-and-basis-of-preparation Note 1 - Nature of the Business and Basis of Preparation Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net Note 3 - Property and Equipment, Net Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Long-term Loans Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-4-longterm-loans Note 4 - Long-term Loans Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Related Party Transactions Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-5-related-party-transactions Note 5 - Related Party Transactions Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Income Taxes Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-6-income-taxes Note 6 - Income Taxes Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Equity (Deficit) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-7-equity-deficit Note 7 - Equity (Deficit) Notes 12 false false R13.htm 012 - Disclosure - Note 8 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-8-employee-defined-contribution-plan Note 8 - Employee Defined Contribution Plan Notes 13 false false R14.htm 013 - Disclosure - Note 9 - Net Loss Per Share Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-9-net-loss-per-share Note 9 - Net Loss Per Share Notes 14 false false R15.htm 014 - Disclosure - Note 10 - Lease Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease- Note 10 - Lease Notes 15 false false R16.htm 015 - Disclosure - Note 11 - Share-based Compensation Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-11-sharebased-compensation Note 11 - Share-based Compensation Notes 16 false false R17.htm 016 - Disclosure - Note 12 - Subsequent Event Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-12-subsequent-event Note 12 - Subsequent Event Notes 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20190331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies 18 false false R19.htm 018 - Disclosure - Note 1 - Nature of the Business and Basis of Preparation (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-1-nature-of-the-business-and-basis-of-preparation-tables Note 1 - Nature of the Business and Basis of Preparation (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-1-nature-of-the-business-and-basis-of-preparation 19 false false R20.htm 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies 20 false false R21.htm 020 - Disclosure - Note 3 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net-tables Note 3 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net 21 false false R22.htm 021 - Disclosure - Note 7 - Equity (Deficit) (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-7-equity-deficit-tables Note 7 - Equity (Deficit) (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-7-equity-deficit 22 false false R23.htm 022 - Disclosure - Note 9 - Net Loss Per Share (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-9-net-loss-per-share-tables Note 9 - Net Loss Per Share (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-9-net-loss-per-share 23 false false R24.htm 023 - Disclosure - Note 10 - Lease (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-tables Note 10 - Lease (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease- 24 false false R25.htm 024 - Disclosure - Note 11 - Share-based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-11-sharebased-compensation-tables Note 11 - Share-based Compensation (Tables) Tables http://www.beyondspringpharma.com/20190331/role/statement-note-11-sharebased-compensation 25 false false R26.htm 025 - Disclosure - Note 1 - Nature of the Business and Basis of Preparation - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-1-nature-of-the-business-and-basis-of-preparation-schedule-of-subsidiaries-details Note 1 - Nature of the Business and Basis of Preparation - Schedule of Subsidiaries (Details) Details 26 false false R27.htm 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies-tables 27 false false R28.htm 027 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies-details Note 2 - Summary of Significant Accounting Policies (Details) Details http://www.beyondspringpharma.com/20190331/role/statement-note-2-summary-of-significant-accounting-policies-tables 28 false false R29.htm 028 - Disclosure - Note 3 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net-details-textual Note 3 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net-tables 29 false false R30.htm 029 - Disclosure - Note 3 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-3-property-and-equipment-net-schedule-of-property-and-equipment-details Note 3 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 30 false false R31.htm 030 - Disclosure - Note 4 - Long-term Loans (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-4-longterm-loans-details-textual Note 4 - Long-term Loans (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-4-longterm-loans 31 false false R32.htm 031 - Disclosure - Note 5 - Related Party Transactions (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-5-related-party-transactions-details-textual Note 5 - Related Party Transactions (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-5-related-party-transactions 32 false false R33.htm 032 - Disclosure - Note 6 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-6-income-taxes-details-textual Note 6 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-6-income-taxes 33 false false R34.htm 033 - Disclosure - Note 7 - Equity (Deficit) - Schedule of Stockholders' Equity (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-7-equity-deficit-schedule-of-stockholders-equity-details Note 7 - Equity (Deficit) - Schedule of Stockholders' Equity (Details) Details http://www.beyondspringpharma.com/20190331/role/statement-note-7-equity-deficit-tables 34 false false R35.htm 034 - Disclosure - Note 8 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-8-employee-defined-contribution-plan-details-textual Note 8 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-8-employee-defined-contribution-plan 35 false false R36.htm 035 - Disclosure - Note 9 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-9-net-loss-per-share-basic-and-diluted-net-loss-per-share-details Note 9 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Details 36 false false R37.htm 036 - Disclosure - Note 10 - Lease (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-details-textual Note 10 - Lease (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-tables 37 false false R38.htm 037 - Disclosure - Note 10 - Lease - Supplement Balance Sheet Information Related to Leases (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-supplement-balance-sheet-information-related-to-leases-details Note 10 - Lease - Supplement Balance Sheet Information Related to Leases (Details) Details 38 false false R39.htm 038 - Disclosure - Note 10 - Lease - Maturities of Lease Liabilities (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-maturities-of-lease-liabilities-details Note 10 - Lease - Maturities of Lease Liabilities (Details) Details 39 false false R40.htm 039 - Disclosure - Note 10 - Lease - Operating Lease Disclosure (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-operating-lease-disclosure-details Note 10 - Lease - Operating Lease Disclosure (Details) Details 40 false false R41.htm 040 - Disclosure - Note 10 - Lease - Future Minimum Lease Payments Under Operating Lease (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-10-lease-future-minimum-lease-payments-under-operating-lease-details Note 10 - Lease - Future Minimum Lease Payments Under Operating Lease (Details) Details 41 false false R42.htm 041 - Disclosure - Note 11 - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-11-sharebased-compensation-sharebased-compensation-expense-details Note 11 - Share-based Compensation - Share-based Compensation Expense (Details) Details 42 false false R43.htm 042 - Disclosure - Note 12 - Subsequent Event (Details Textual) Sheet http://www.beyondspringpharma.com/20190331/role/statement-note-12-subsequent-event-details-textual Note 12 - Subsequent Event (Details Textual) Details http://www.beyondspringpharma.com/20190331/role/statement-note-12-subsequent-event 43 false false All Reports Book All Reports bysi-20190331.xml bysi-20190331.xsd bysi-20190331_cal.xml bysi-20190331_def.xml bysi-20190331_lab.xml bysi-20190331_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true